In Reply On behalf of my colleagues, I thank Gnecchi-Ruscone and Restifo Pecorella for their letter and questions about our research. We agree that the dosage of aspirin is important, but as explained in the Limitations section of our article,1 we unfortunately do not have that information in the registry. As part of our education program at our quality meetings, we advocated for the use of low-dose aspirin, as recommended in the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed,2 but we do not know what dose was actually given. In addition, as is the case with all discharge medications, compliance may be an issue, so our study is based on the surgeon’s recommended or prescribed anticoagulation postoperatively.3
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Hallstrom B. Which Aspirin to Choose?—Reply. JAMA Surg. 2019;154(6):565–566. doi:10.1001/jamasurg.2019.0121
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: